^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

FT873

i
Other names: FT873, B7-H3-targeted CAR NK cell therapy, hnCD16/IL-15RF/CD38KO engineered iPSC-derived B7-H3-targeted CAR NK cell therapy, iPSC-derived camB7-H3 CAR NK cell therapy, FT573
Associations
Trials
Company:
Fate Therap
Drug class:
B7-H3 inhibitor
Associations
Trials